Diabetic ketoacidosis.
Calimag APP, Chlebek S, Lerma EV, Chaiban JT.
Dis Mon. 2023 Mar;69(3):101418. doi: 10.1016/j.disamonth.2022.101418. Epub 2022 May 14.
Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.
Chow E, Clement S, Garg R.
BMJ Open Diabetes Res Care. 2023 Oct;11(5):e003666. doi: 10.1136/bmjdrc-2023-003666.
Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Fayfman M, Pasquel FJ, Umpierrez GE.
Med Clin North Am. 2017 May;101(3):587-606. doi: 10.1016/j.mcna.2016.12.011.
Diabetic Ketoacidosis: Evaluation and Treatment.
Veauthier B, Levy-Grau B.
Am Fam Physician. 2024 Nov;110(5):476-486.
Diabetic ketoacidosis.
Dhatariya KK, Glaser NS, Codner E, Umpierrez GE.
Nat Rev Dis Primers. 2020 May 14;6(1):40. doi: 10.1038/s41572-020-0165-1.
A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus.
Wysham C, Bindal A, Levrat-Guillen F, Kostadinova D, Poon Y.
Diabetes Obes Metab. 2025 May;27(5):2750-2767. doi: 10.1111/dom.16282. Epub 2025 Mar 3.
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management.
Nyenwe EA, Kitabchi AE.
Metabolism. 2016 Apr;65(4):507-21. doi: 10.1016/j.metabol.2015.12.007. Epub 2015 Dec 19.
Euglycemic Diabetic Ketoacidosis: How Is It Different from Diabetic Ketoacidosis.
Ju HH.
Crit Care Nurs Clin North Am. 2025 Mar;37(1):157-165. doi: 10.1016/j.cnc.2024.08.004. Epub 2024 Sep 23.
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Goldenberg RM, Berard LD, Cheng AYY, Gilbert JD, Verma S, Woo VC, Yale JF.
Clin Ther. 2016 Dec;38(12):2654-2664.e1. doi: 10.1016/j.clinthera.2016.11.002.
Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.
Oriot P, Hermans MP.
Acta Clin Belg. 2022 Feb;77(1):113-117. doi: 10.1080/17843286.2020.1780390. Epub 2020 Jun 16.
